|
C11ORF61 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.992100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.307380E-01 |
| Normal-vs-Stage2 |
3.236400E-01 |
| Normal-vs-Stage3 |
2.638600E-01 |
| Normal-vs-Stage4 |
8.653600E-01 |
| Stage1-vs-Stage2 |
7.544600E-01 |
| Stage1-vs-Stage3 |
5.296900E-03 |
| Stage1-vs-Stage4 |
5.760200E-01 |
| Stage2-vs-Stage3 |
1.159790E-01 |
| Stage2-vs-Stage4 |
5.539200E-01 |
| Stage3-vs-Stage4 |
3.625600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.620400E-02 |
| Normal-vs-AfricanAmerican |
2.145000E-01 |
| Normal-vs-Asian |
6.238800E-01 |
| Caucasian-vs-AfricanAmerican |
8.997800E-01 |
| Caucasian-vs-Asian |
8.619000E-01 |
| AfricanAmerican-vs-Asian |
8.325800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.137700E-02 |
| Normal-vs-Female |
4.158800E-01 |
| Male-vs-Female |
2.960800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.907200E-01 |
| Normal-vs-Extreme_Weight |
1.785600E-01 |
| Normal-vs-Obese |
1.311970E-01 |
| Normal-vs-Extreme_Obese |
9.416000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.716200E-01 |
| Normal_Weight-vs-Obese |
6.234000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.525000E-01 |
| Extreme_Weight-vs-Obese |
8.041600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.249400E-01 |
| Obese-vs-Extreme_Obese |
4.385200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.872780E-01 |
| Normal-vs-Age(41-60Yrs) |
2.250000E-02 |
| Normal-vs-Age(61-80Yrs) |
2.285400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.551400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.245200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.529400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.637700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.886750E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.140000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.405000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.816400E-04 |
| Normal-VS-Type2 PRCC |
2.203200E-03 |
| Normal-VS-KIRP CIMP |
6.890800E-01 |
| Normal-VS-Unclassified PRCC |
2.767400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.11022302462516E-16 |
| Type1 PRCC-VS-KIRP CIMP |
6.070200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.695800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.123180E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.16789999999412E-05 |
| KIRP CIMP-VS-Unclassified PRCC |
2.835000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.344200E-01 |
| Normal-vs-N1 |
8.809200E-01 |
| Normal-vs-N2 |
1.243200E-01 |
| N0-vs-N1 |
6.131800E-01 |
| N0-vs-N2 |
1.781190E-03 |
| N1-vs-N2 |
2.040400E-01 |
|
|
